Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions

We previously reported that the local control of pulmonary metastases from colorectal cancer (CRC) following stereotactic body radiotherapy (SBRT) with moderate prescription dose was relatively worse. We investigated the treatment outcomes and toxicities of patients with oligometastases from CRC tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Atsuya, Sanuki, Naoko, Tsurugai, Yuichiro, Oku, Yohei, Aoki, Yousuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Regular Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973648/
https://www.ncbi.nlm.nih.gov/pubmed/26983981
http://dx.doi.org/10.1093/jrr/rrw029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973648/
https://www.ncbi.nlm.nih.gov/pubmed/26983981
http://dx.doi.org/10.1093/jrr/rrw029

Ejemplares similares